Skip to main content

Advertisement

Springer Nature Link
Log in

The clinical significance of methylenetetrahydrofolate reductase (MTHFR) polymorphisms in acute lymphoblastic leukemia

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Genetic polymorphisms in the folate metabolic pathway may contribute to the susceptibility to childhood ALL because they affect the DNA synthesis, methylation, and repair. The most common polymorphisms are methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C. The current study aimed at detecting the frequency of these two genetic polymorphisms in de novo ALL patients, and to clarify their impact on the response to induction chemotherapy, as well as treatment toxicity. MTHFR C677T and A1298C polymorphisms were tested in 30 de novo ALL patients by restriction fragment length polymerase chain reaction technique. Thirty normal age- and sex-matched subjects were subjected to the same analysis as a control group. The frequency of MTHFR A1298C gene polymorphism was significantly lower in ALL patients than the controls thus showing a protective effect. The two polymorphisms had no effect on the response to induction chemotherapy. As regards the treatment toxicity, MTHFR C677T polymorphism was associated with marked thrombocytopenia, while A1298C polymorphism was associated with hepatic toxicity. Identifying predictors of methotrexate sensitivity may lead to the development of individualized treatment strategies with improved efficacy and reduced toxicity as well as adjusting the initial methotrexate dose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  • Aplenc R, Thompson J, Han P et al (2005) Methylene-tetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 65:2482–2487

    Article  PubMed  CAS  Google Scholar 

  • Chatzidakis K, Goulas A, Athanassiadou-Piperopoulou F et al (2006) Methylenetetrahydro-folate reductase C677T polymorphisms: association with risk for childhood acute lymphoblastic leukaemia and response during the initial phase of chemotherapy in Greek patients. Pediatr Blood Cancer 47(2):146

    Article  Google Scholar 

  • Chiusolo P, Reddiconto G, Cimino G et al (2004) Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population. Haematologica 89:139

    PubMed  CAS  Google Scholar 

  • Costea I, Moghrabi A, Laverdiere C et al (2006) Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia. Haematologica 91:1113

    PubMed  CAS  Google Scholar 

  • Deligezer U, Akisik E, Dalay N (2003) Genotyping of the MTHFR gene polymorphism, C677T in patients with leukemia by melting curve analysis. Mol Diagn 7(3–4):181

    Article  PubMed  Google Scholar 

  • Fazili Z, Pfeiffer CM, Zhang M et al (2008) Influence of 5, 10-methylenetetrahydrofolate reductase polymorphism on whole-blood folate concentrations measured by LC-MS/MS, microbiologic assay, and bio-rad radioassay. Clin Chem 54(1):197

    Article  PubMed  CAS  Google Scholar 

  • Giuseppe T, Innocenti F (2006) MTHFR polymorphisms and ALL risk: a challenge. Leuk Lymphoma 47(7):1203

    Article  Google Scholar 

  • Jone RD, Hooijberg JH, Betrand D et al (2005) Effect of polymorphisms in folate related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood 106:717

    Article  Google Scholar 

  • Kasap M, Sazci A, Ergul E et al (2006) Molecular phylogenetic analysis of methylenetetrahydrofolate reductase family of proteins. Mol Phylogenet Evol 42(3):838

    Article  PubMed  Google Scholar 

  • Kim NK, Chang SY, Jang MD et al (2006) Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood ALL. Anticancer Res 26(4B):2879

    PubMed  CAS  Google Scholar 

  • Krajinovic M, Lamothe S, Labuda D et al (2004) Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103(1):252

    Article  PubMed  CAS  Google Scholar 

  • Marie J (1999) Drug resistance and its modifications in hematological malignancies. In: Degos L, Lich D, Lowenberg B (eds) Textbook of malignant haematology, 1st edn. Taylor & Francis, Boca Raton, p 299

    Google Scholar 

  • Mattsom MP, Kruman II, Duan W (2002) Folic acid and homocysteine in age-related diseases. Aging Res Reviewers 1:95

    Article  Google Scholar 

  • Oliveira E, Alves S, Quental S et al (2005) The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 27(8):425

    Article  PubMed  Google Scholar 

  • Petra BG, Janez J, Vita D (2007) Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 48(4):786

    Article  PubMed  CAS  Google Scholar 

  • Reddy H, Jamil K (2006) Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood ALL in an Indian population. Leuk Lymphoma 44(7):1203

    Google Scholar 

  • Schnakenberg E, Mehles A, Cario G et al (2005) Polymorphism of methylenetetarhydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Gen 6:23

    Article  Google Scholar 

  • Skibola CF, Smith MT, Kane L et al (1999) Polymorphism in the MTHFR gene is associated with susceptibility to acute leukemia in adults. Natl Acad Sci USA 96:12810

    Article  CAS  Google Scholar 

  • Thirumaran RK, Gast A, Flohr T et al (2005) MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 106(7):2590

    Article  PubMed  CAS  Google Scholar 

  • Timuragaoglu A, Dizlek S, Uysalgil N et al (2006) Methylenetetrahydrofolate reductase C677T gene polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy. Ann Hematol 85:863

    Article  PubMed  CAS  Google Scholar 

  • Wilson M, Sidhom I (2007) Polymorphisms of the methylenete-trahydrofolate reductase gene and risk of childhood acute lymphoblastic leukemia. In: The Third International Conference of the Egyptian Society of Haematology and Research, 11–12 April 2007

  • Zanrosso CW et al (2006) The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk Res 30:477

    Article  PubMed  CAS  Google Scholar 

  • Zintzaras E (2006) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 51(7):618

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Clinical and Chemical Pathology, Cairo University, Cairo, Egypt

    Hanaa H. Arnaout, Mervat M. Khorshied, Iman A. Shaheen, Heba M. Gouda, Noha Y. Ibrahim & Naglaa F. Koura

  2. Faculty of Medicine, Department of Oncology, Cairo University, Cairo, Egypt

    Noha Y. Ibrahim

Authors
  1. Hanaa H. Arnaout
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Mervat M. Khorshied
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Iman A. Shaheen
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Heba M. Gouda
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Noha Y. Ibrahim
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Naglaa F. Koura
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Noha Y. Ibrahim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arnaout, H.H., Khorshied, M.M., Shaheen, I.A. et al. The clinical significance of methylenetetrahydrofolate reductase (MTHFR) polymorphisms in acute lymphoblastic leukemia. Comp Clin Pathol 21, 39–47 (2012). https://doi.org/10.1007/s00580-010-1062-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-010-1062-x

Keywords